新产品编号:2308647
Chemical Name: 3-(2-Benzyl-10-hydroxy-5-oxo-2,3,4,5-tetrahydro-1H-1-benzopyran[4,3-c]pyridin-8-yl)butyric acid ethyl ester
项目整合开发状态: Preclinical
项目研究机构: Kos Pharmaceuticals (Originator), University of Florida (Originator)
合成路线:Horner-Emmons condensation of 3',5'-di(benzyloxy)acetophenone (I) with triethyl phosphonoacetate yields the unsaturated ester (II).Catalytic double bond hydrogenation in (II),with simultaneous benzyl group hydrogenolysis,leads to the substituted resorcinol (III).This is then subjected to Pechmann cyclization with ethyl 1-benzyl-3-oxopiperidine-4-carboxylate (IV) in the presence of H2SO4 and POCl3 to provide the target benzopyranopyridine compound.
📌 参考资料/链接:
参考文献标题:Soft cannabinoid analogues as potential anti-glaucoma agents
文献作者:Buchwald,A.; Derendorf,H.; Ji,F.; Nagaraja,N.Y.; Wu,W.M.; Bodor,N.
参考来源:Pharmazie 2002,57(2),108